$ 261.44+4.96 (+1.93%)
AperturaPrecio de apertura
—MínimoPrecio mínimo de hoy
—Máximo de 52 semanasMáximo en 52 semanas
—MáximoPrecio máximo de hoy
—Mínimo de 52 semanasMínimo en 52 semanas
—Cap. de mercadoValor total de la empresa
618.09BVolumen de hoyAcciones negociadas hoy
6.05MVolumen promedioPromedio de acciones negociadas
7.5MRelación P/ERelación precio-beneficio
29.65Perfil de la empresa
Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.
Fecha de salida a bolsa
1962-01-02Sede
New Brunswick, USCEO
Joaquin DuatoSector
HealthcareIndustria
Drug Manufacturers - GeneralEstados financieros
Resultados
Noticias

Pfizer's Yield Is Three Times Bigger. Johnson & Johnson's Dividend Has Something Pfizer Does Not
2 days agoJNJ247wallst.com

Johnson & Johnson Has Dividend Royalty Status. Does That Make It a Buy?
3 days agoJNJ247wallst.com

The Crash-Proof Portfolio: 5 Elite Dividend Stocks Built to Survive a Market Meltdown
3 days agoJNJ247wallst.com

Johnson & Johnson (NYSE:JNJ) vs. Fortress Biotech (NASDAQ:FBIO) Head to Head Review
3 days agoJNJdefenseworld.net

Rep. Lloyd Doggett Purchases Shares of Johnson & Johnson (NYSE:JNJ)
3 days agoJNJdefenseworld.net

Home Depot (NYSE:HD) Stock Purchase Disclosed by Rep. Lloyd Doggett
3 days agoJNJdefenseworld.net
Noticias
Empresas relacionadas
ABBVAbbVie Inc.
276.47
AMGNAmgen Inc.
414.87
AZNAstraZeneca PLC
159.20
BMYBristol-Myers Squibb Company
59.12














